Assessment of prognostic factors in epithelial ovarian cancer
EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, cilt.1, sa.2, ss.61-68, 2017 (Hakemli Dergi)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 1 Sayı: 2
- Basım Tarihi: 2017
- Doi Numarası: 10.14744/ejmo.2017.43531
- Dergi Adı: EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY
- Derginin Tarandığı İndeksler: Other Indexes
- Sayfa Sayıları: ss.61-68
- Anahtar Kelimeler: Chemotherapy, mortality, ovarian cancer, prognosis, residual tumor, STAGE-III, PHASE-III, FOLLOW-UP, SURVIVAL, SURGERY, RISK, CARCINOMA, THERAPY, ASCITES, CYCLOPHOSPHAMIDE
- Marmara Üniversitesi Adresli: Hayır
Özet
Objectives: Ovarian cancer is the second most common gynecological cancer, and has a 5-year survival rate of about 40% to 45%. This ratio ranges from 15% to 95%, based on prognostic factors. There are numerous clinical, pathological and biological factors related to prognosis. The aim of this study was to assess prognostic factors in advanced epithelial ovarian cancer.